Table 4. Clinical outcomes between SED and non-SED groups.
| Event rate (%) | Crude | IPW Adjusted | ||||
|---|---|---|---|---|---|---|
| Overall (n = 175) | SED (n = 32) | Non-SED (n = 143) | p-value | HR (95% CI) | p-value | |
| All cause death | 8 (4.6) | 3 (9.4) | 5 (3.5) | 0.27 | - | - |
| Cardiac death | 2 (1.1) | 2 (6.3) | 0 (0.0) | 0.003 | - | - |
| Non-cardiac death | 6 (3.4) | 1 (3.1) | 5 (3.5) | 0.71 | - | - |
| Target-vessel MI | 2 (1.1) | 2 (6.3) | 0 (0.0) | 0.003 | - | - |
| Definite stent thrombosis | 1 (0.6) | 1 (3.1) | 0 (0.0) | 0.04 | - | - |
| Probable stent thrombosis | 0 (0.0) | 0 (0.0) | 0 (0.0) | NE | - | - |
| Any TLR | 11 (6.3) | 5 (15.6) | 6 (4.2) | 0.04 | - | - |
| CD-TLR | 11 (6.3) | 5 (15.6) | 6 (4.2) | 0.04 | - | - |
| Any TVR | 12 (6.9) | 5 (15.6) | 7 (4.9) | 0.07 | - | - |
| CD-TVR | 11 (6.3) | 5 (15.6) | 6 (4.2) | 0.04 | - | - |
| MACE | 13 (7.4) | 7 (21.9) | 6 (4.2) | 0.003 | 3.43 (1.09–10.81) | 0.035 |
P-value in the crude-population was analyzed by the log-rank method. CD, clinically-driven; CI, confidence interval; HR, hazard ratio; IPW, inverse probability weighted; MACE, major adverse cardiovascular events; MI, myocardial infarction; NE, not estimable; SED, stent edge dissection; TLR, target lesion revascularization; TVR, target vessel revascularization.